Clinical Briefing Report

Adobe Stock
Elana Gotkine
2 min read
Significantly improved event-free and overall survival seen with enfortumab vedotin-pembrolizumab versus cisplatin-gemcitabine
Adobe Stock
Lori Solomon
1 min read
However, other sedentary behaviors did not have the same association, suggesting what one does while sitting may matter more than previously thought
Read More
Clinical Briefing Report
clinicalbriefingreport.com